Santosh Shanbhag - Akili CFO Treasurer

Insider

Santosh Shanbhag is CFO Treasurer of Akili Inc
Age 47
Phone617 313 8853
Webhttps://www.akiliinteractive.com

Santosh Shanbhag Latest Insider Activity

Tracking and analyzing the buying and selling activities of Santosh Shanbhag against Akili stock is an integral part of due diligence when investing in Akili. Santosh Shanbhag insider activity provides valuable insight into whether Akili is net buyers or sellers over its current business cycle. Note, Akili insiders must abide by specific rules, including filing SEC forms every time they buy or sell Akili'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Akili Management Efficiency

The company has return on total asset (ROA) of (0.3662) % which means that it has lost $0.3662 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.6806) %, meaning that it created substantial loss on money invested by shareholders. Akili's management efficiency ratios could be used to measure how well Akili manages its routine affairs as well as how well it operates its assets and liabilities.
Akili Inc currently holds 15.48 M in liabilities with Debt to Equity (D/E) ratio of 0.79, which is about average as compared to similar companies. Akili Inc has a current ratio of 4.68, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Akili's use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Max WygodForian Inc
37
Patrick NelliHealth Catalyst
N/A
Dave RossHealth Catalyst
N/A
Michael VeseyForian Inc
62
Tyson MurdockHealthEquity
53
Jawad ShaikhStreamline Health Solutions
N/A
Mark GroveForian Inc
N/A
Jon BoumsteinNational Research Corp
N/A
Daniel TanEUDA Health Holdings
44
Jacob GoldbergerStreamline Health Solutions
N/A
Steven SobakEUDA Health Holdings
78
Tyler DanielsonFOXO Technologies
N/A
Gregory MSNational Research Corp
N/A
David TerrellForian Inc
N/A
Daniel BurtonHealth Catalyst
49
MB CCSStreamline Health Solutions
N/A
Andrew DouglasForian Inc
N/A
Adam DublinForian Inc
59
Jona RaaschNational Research Corp
65
Wei ChenEUDA Health Holdings
40
CPA CPANational Research Corp
66
Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. Akili operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 127 people. Akili Inc (AKLI) is traded on NASDAQ Exchange in USA and employs 68 people.

Management Performance

Akili Inc Leadership Team

Elected by the shareholders, the Akili's board of directors comprises two types of representatives: Akili inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Akili. The board's role is to monitor Akili's management team and ensure that shareholders' interests are well served. Akili's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Akili's outside directors are responsible for providing unbiased perspectives on the board's policies.
Carl Gottlieb, Chief Officer
Scott Kollins, Chief Officer
Jacqueline JD, General Officer
Barrie Brian, VP People
Adam MD, Chief Cofounder
Walter II, CoFounder Chairman
Julie DiCarlo, VP Communications
Jonathan David, Chief Officer
Santosh Shanbhag, CFO Treasurer
Matthew MBA, CEO President
Matthew Omernick, CoFounder Officer
Caty Reid, VP Communications
Walter Martucci, CEO CoFounder

Akili Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Akili a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Consideration for investing in Akili Stock

If you are still planning to invest in Akili Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Akili's history and understand the potential risks before investing.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Stocks Directory
Find actively traded stocks across global markets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals